Medicinal Plant Extracts Breakthroughs in Treating Infectious Diseases

The Indian Medicinal Plant extract market is expected to grow at a CAGR of around 17% during the forecasted period of 2017-2022, says RNCOS in its Indian Medicinal Plant Extract report.

RNCOS LogoRNCOS Logo

Noida, Uttar Pradesh, May 23, 2017 /India PRwire/ -- Indian medicinal plant extract industry has been witnessing significant growth in the recent years due to the recent upsurge in use of herbal medicines and cosmetics. Medicinal Plants are highly esteemed all over the world as a rich source of therapeutic agents for the prevention of diseases and ailments and hence cultivation of medicinal plants especially high value medicinal plants is creating new dimension in the field of Agriculture.

According to our latest research report, "Indian Medicinal Plant Extract Market Outlook 2022", herbal market is expected to grow in the coming years on account of factors like shift in trend from synthetic to herbal medicine, herbal products gaining popularity in developing and developed countries owing to its natural origin and lesser side effects, key investments and expansion in Indian herbal extract sector.

Herbal Plants has been one of the major elements for traditional system of medicines. There has been significant shift in consumers preferences towards natural products which are made of medicinal plant extracts as a result of the alarming side effects caused by the synthetic drugs which has led many drug manufactures to use more and more of plant extracts for the manufacturing of the medicinal products for curing infectious diseases.

Government initiatives are also driving the industry as government is emphasizing on the conservation of natural resources by formulating various acts for the conservation and protection of forests containing medicinal plants and cultivation of medicinal species along with establishment of medicinal plants processing zones. Hence due to rekindling in the demand for traditional medicines globally, there seem to be huge potential in this sector and India having a diversified biodiversity has a tremendous potential and advantage in this emerging area.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM890.htm

Check Related REPORTS on: http://www.rncos.com/Food&Beverages.htm

Notes to Editor

About RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.


Journalists and Bloggers
Visit India PRwire for Journalists for releases, photos, email alerts and customized feeds just for Media.

If you have any query regarding information in the press releases, please contact the company listed in the press release itself. Please do not call India PRwire, we will be unable to assist you with your inquiry.


RNCOS E-Services Pvt. Ltd. recent press release(s)


RNCOS White Paper: The Indian Health Insurance Sector

"The standalone health insurance industry continues to show the fastest growth rate on account of constant innovation by the players, says RNCOS"

Global Parkinson's Disease Drugs Market to Reach Approximate Value of US$ 5 Billion by 2022

"Growing aged population, rising healthcare expenditure, and increasing awareness about Parkinson's disease treatment options, likely to drive the Global Parkinson's Disease Drugs Market", says RNCOS.

Increasing Consumer Preference of Healthy Snacks Propelling Gourmet Popcorn Industry

Gourmet popcorns are becoming the consumers preference as a healthy snacks, says RNCOS in its latest research report.

Usage of Nanomaterial Propelling the Europe Cosmeceutical Market

Increased usage of nonmaterial in cosmetic products is driving the cosmeceutical market, says RNCOS in its latest research report.

Global Hemophilia Therapeutics Market to Reach US$ 13 Billion by 2022

"Grants and tax credits, rising healthcare expenditure, and increasing awareness about hemophilia likely to drive the Global Hemophilia Therapeutics Market", says RNCOS.